In Vitro Interactions of Echinocandins with Triazoles against Multidrug-Resistant Candida auris

Antimicrobial Agents and Chemotherapy
Hamed FakhimHamid Badali

Abstract

We determined the in vitro interactions between echinocandins and azoles against 10 multidrug-resistant Candida auris strains by use of a microdilution checkerboard technique. Our results suggest synergistic interactions between micafungin and voriconazole with fractional inhibitory concentration index (FICI) values of 0.15 to 0.5, and we observed indifferent interactions when micafungin was combined with fluconazole (FICI, 0.62 to 1.5). Combinations of caspofungin with fluconazole or voriconazole exhibited indifferent interactions. No antagonism was observed for any combination.

References

Jun 14, 2003·The Journal of Antimicrobial Chemotherapy·F C Odds
Jan 4, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·O A CornelyUNKNOWN ESCMID Fungal Infection Study Group
Sep 21, 2013·Emerging Infectious Diseases·Anuradha ChowdharyJacques F Meis
Oct 10, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M C ArendrupUNKNOWN European Confederation of Medical Mycology
Dec 21, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A ChowdharyJ F Meis
Jun 26, 2014·Emerging Infectious Diseases·Rindidzani E MagoboNelesh P Govender
Jan 27, 2016·Mycoses·Sarah Santos GonçalvesArnaldo Lopes Colombo
Jul 28, 2016·The Journal of Infection·Belinda CalvoArnaldo Lopes Colombo
Oct 26, 2016·Antimicrobial Resistance and Infection Control·Silke SchelenzMatthew C Fisher
Nov 18, 2016·Antimicrobial Agents and Chemotherapy·Gwénolé PrigentFrançoise Botterel
Nov 25, 2016·Journal of Clinical Microbiology·Masako MizusawaSean X Zhang
Dec 17, 2016·Emerging Infectious Diseases·Soraya E Morales-LópezJosé Y Rodríguez
Dec 19, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shawn R LockhartAnastasia P Litvintseva
Dec 29, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S VallabhaneniT M Chiller
Jan 19, 2017·Emerging Infectious Diseases·Ronen Ben-AmiTalya Finn
Feb 17, 2017·Medical Mycology·Andrew M BormanElizabeth M Johnson
Mar 24, 2017·The Journal of Antimicrobial Chemotherapy·Shivaprakash M RudramurthyAnup Ghosh
May 10, 2017·Antimicrobial Agents and Chemotherapy·Elizabeth L BerkowShawn R Lockhart
Jul 8, 2017·Mycoses·Jalila MohsinAbdullah M S Al-Hatmi

❮ Previous
Next ❯

Citations

Nov 8, 2017·Expert Review of Anti-infective Therapy·Matthew William McCarthy, Thomas J Walsh
Nov 17, 2017·Clinical Microbiology Reviews·Anna Jeffery-SmithColin S Brown
May 30, 2019·Journal of Medical Microbiology·Lingyue SunJin Yu
Feb 19, 2019·Mycoses·Shabir A Lone, Aijaz Ahmad
Apr 20, 2019·Frontiers in Cellular and Infection Microbiology·Haroldo Cesar de OliveiraOscar Zaragoza
Sep 26, 2020·Journal of Fungi·Elizabete de Souza CândidoOctavio Luiz Franco
May 28, 2019·Medical Mycology·Fruzsina NagyRenátó Kovács
Aug 8, 2018·Medical Mycology·Kaitlin ForsbergSnigdha Vallabhaneni
Jun 9, 2020·Frontiers in Microbiology·Fruzsina NagyRenátó Kovács
Jul 2, 2019·Frontiers in Microbiology·Linh Thi Truc PhamPopchai Ngamskulrungroj
Aug 20, 2019·Internal Medicine Journal·Chong W OngUNKNOWN Australian and New Zealand Mycoses Interest Group (ANZMIG); and the Healthcare Infection Control Special Interest Group (HIC
Dec 20, 2019·Journal of Clinical Microbiology·YanChun ZhuSudha Chaturvedi
Jul 24, 2020·Current Fungal Infection Reports·Alison R NovakScott W Mueller
Feb 8, 2019·Journal of Clinical Microbiology·Yong Jun KwonMyung Geun Shin
Dec 10, 2020·Scientific Reports·Patrick SchwarzEric Dannaoui
Jun 17, 2020·International Journal of Antimicrobial Agents·Thayná Lopes BarretoKelly Ishida
Nov 20, 2020·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Heather R DavisGeorge A Pankey
Jan 20, 2020·International Journal of Antimicrobial Agents·A L BidaudE Dannaoui
Feb 18, 2020·Critical Reviews in Analytical Chemistry·Gabriel Davi MarenaMarlus Chorilli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.